4D Molecular Therapeutics Inc
(FDMT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Sales | 6,986 | 0 | 0 | 0 |
| Gross Profit | 6,986 | N/A | N/A | N/A |
| Operating Expenses | 57,750 | 0 | 0 | 0 |
| Operating Income | -50,764 | N/A | N/A | N/A |
| Other Income | 1,458 | 0 | 0 | 0 |
| Pre-tax Income | -49,306 | 0 | 0 | 0 |
| Net Income Continuous | -49,306 | N/A | N/A | N/A |
| Net Income | $-49,306 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -9.59 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -9.59 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -9.59 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -9.59 | N/A | N/A | N/A |
| EBITDA(a) | $-49,760 | $N/A | $N/A | $N/A |